Published by Alexander Bueso on 11th June 2020
(Sharecast News) - Spain's Grifols has begun production of its hyperimmune globulin, the first treatment specifically designed for use against SARS-CoV-2.
URL: http://www.digitallook.com/dl/news/story/30781347/...